Vertex Pharmaceuticals
VRTX | NASDAQ
$552.75
-$6.13 (-1.10%)
Nov 2, 2026, 3:56 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 5.09B | 4.57B | 10.37B | 10.5B | 6.8B | 5.99B |
Short-Term Investments | 1.52B | 1.55B | 849.2M | 274.5M | 729.9M | 670.7M |
Long-Term Investments | 5.81B | 5.11B | 2.5B | 112.2M | n/a | n/a |
Other Long-Term Assets | 1.14B | 999.3M | 895.3M | 409.6M | 110.8M | 49.3M |
Receivables | 2.05B | 1.61B | 1.56B | 1.44B | 1.14B | 885.4M |
Inventory | 1.69B | 1.21B | 738.8M | 460.6M | 353.1M | 280.78M |
Other Current Assets | 748.6M | 206.5M | 86.1M | 121.9M | 103.7M | 79.72M |
Total Current Assets | 11.2B | 9.6B | 14.14B | 13.23B | 9.56B | 8.13B |
Property-Plant & Equipment | 3.08B | 2.58B | 1.45B | 1.46B | 1.42B | 1.28B |
Goodwill & Intangibles | 1.51B | 1.91B | 1.93B | 1.69B | 1.4B | 1.4B |
Total Long-Term Assets | 14.94B | 12.94B | 8.59B | 4.92B | 3.87B | 3.62B |
Total Assets | 26.14B | 22.53B | 22.73B | 18.15B | 13.43B | 11.75B |
Account Payables | 461.7M | 413M | 364.9M | 303.9M | 195M | 155.1M |
Deferred Revenue | 171.8M | 206.8M | 170.3M | 159.6M | 171.7M | 191.5M |
Short-Term Debt | 82.8M | 92.3M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 2.75B | 2.5B | 50.7M | 62.5M | 16.5M | 83.5M |
Total Current Liabilities | 3.86B | 3.56B | 3.55B | 2.74B | 2.14B | 1.88B |
Long-Term Debt | 1.85B | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | -1.49B | 901.8M | 877.7M | 685.8M | 303.3M | 298M |
Total Long-Term Liabilities | 3.62B | 2.56B | 1.6B | 1.5B | 1.19B | 1.19B |
Total Liabilities | 7.48B | 6.12B | 5.15B | 4.24B | 3.33B | 3.07B |
Total Debt | 3.88B | 1.75B | 808.4M | 899.7M | 967.4M | 931.9M |
Book Value | 18.67B | 16.41B | 17.58B | 13.91B | 10.1B | 8.69B |
Book Value Per Share | 72.35 | 63.63 | 67.49 | 53.70 | 38.86 | 32.98 |
Common Stock | 2.5M | 2.6M | 2.6M | 2.6M | 2.5M | 2.6M |
Retained Earnings | 13.56B | 9.61B | 10.14B | 6.52B | 3.2B | 858.67M |
Comprehensive Income | -15.9M | 127.8M | -14.3M | 800K | 15.9M | -68.48M |
Shareholders Equity | 18.67B | 16.41B | 17.58B | 13.91B | 10.1B | 8.69B |
Total Investments | 7.33B | 6.65B | 3.35B | 386.7M | 729.9M | 670.7M |
Add to Watchlist
Select watchlists to add or remove VRTX